Burns clinical trials

Explore recruiting burns clinical trials.

Recruiting burns studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Burns trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

INDICIA: evolution of the initial distribution volume of glucose in the severe burned adults

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of early dexamethasone on major complications and all-cause mortality in severe burns

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

C5041034 - A Phase 1, Open-Label, Randomized, Single Dose, Crossover Study to Estimate the Relative Bioavailability of Etrasimod (PF-07915503) Mini Tablets in Water and 3 Food Vehicles Compared to the Etrasimod (PF-07915503) Clinical IR Tablets Under Fasted Conditions, and to Evaluate Mini Tablet Palatability in Healthy Adult Participants

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered collagen-based skin graft composed of autologous fibroblasts and keratinocytes, for the treatment of patients with deep partial and full-thickness burns

Netherlands, Italy, Belgium, France, Portugal, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre, single-arm, open-label phase II trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the treatment of partial deep dermal and full thickness burns in children in comparison to autologous split-thickness skin grafts (STSG) (BC)

Italy, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Burns trials by city

Burns in Toronto Burns in Vancouver Burns in Montreal Burns in Calgary Burns in Edmonton Burns in Ottawa Burns in Winnipeg Burns in Quebec City Burns in Hamilton Burns in Kitchener Burns in London Burns in Halifax Burns in New York Burns in Los Angeles Burns in Chicago Burns in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease